The Venture Codex Logo

The Venture Codex

Incyclix Bio

600 Park Offices Dr., Suite 355, Durham, NC, 27713, United States

Overview

Develops small molecule inhibitors for advanced cancer treatment.

Total Raised

$52 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Pharmaceutical
Therapeutics

Investment History

  1. Series B

    Apr 2026

    $5M

    Hatteras Venture Partners · Lead

  2. Series B

    Aug 2025

    $11M

    Eshelman VenturesPharmacosmosCape Fear BioCapitalEli Lilly and Company

  3. Series B

    Apr 2022

    $30M

    Eshelman VenturesRA Capital Management

  4. Equity

    Aug 2020

    $6M

    Eshelman Ventures · Lead

Team

Patrick Roberts

CEO and Co-Founder

Jay Strum

Chief Scientific Officer and Co-Founder

John Bisi

Co-Founder/ Senior Vice President

Daniel Klem

Senior Manager Clinical Operations